000 01175 a2200325 4500
005 20250513132853.0
264 0 _c19980202
008 199802s 0 0 eng d
022 _a1060-0280
024 7 _a10.1177/106002809703101209
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMauro, L S
245 0 0 _aIntroduction to coronary artery stents and their pharmacotherapeutic management.
_h[electronic resource]
260 _bThe Annals of pharmacotherapy
_cDec 1997
300 _a1490-8 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnticoagulants
_xadverse effects
650 0 4 _aCoronary Disease
_xetiology
650 0 4 _aCoronary Thrombosis
_xetiology
650 0 4 _aEquipment Design
650 0 4 _aHemorrhage
_xchemically induced
650 0 4 _aHumans
650 0 4 _aPlatelet Aggregation Inhibitors
_xtherapeutic use
650 0 4 _aSecondary Prevention
650 0 4 _aStents
_xadverse effects
700 1 _aBorovicka, M C
700 1 _aKline, S S
773 0 _tThe Annals of pharmacotherapy
_gvol. 31
_gno. 12
_gp. 1490-8
856 4 0 _uhttps://doi.org/10.1177/106002809703101209
_zAvailable from publisher's website
999 _c9385962
_d9385962